Mary Pinder

1.4k total citations
30 papers, 995 citations indexed

About

Mary Pinder is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mary Pinder has authored 30 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mary Pinder's work include Lung Cancer Treatments and Mutations (4 papers), Cancer Treatment and Pharmacology (3 papers) and Cardiac, Anesthesia and Surgical Outcomes (3 papers). Mary Pinder is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Cancer Treatment and Pharmacology (3 papers) and Cardiac, Anesthesia and Surgical Outcomes (3 papers). Mary Pinder collaborates with scholars based in Australia, United States and Germany. Mary Pinder's co-authors include James S. Goodwin, Gabriel N. Hortobágyi, Zhigang Duan, Sharon H. Giordano, Jeffrey Lipman, Rinaldo Bellomo, Peter Vernon van Heerden, Richard Parsons, Brigit Roberts and Hui‐Leng Tan and has published in prestigious journals such as Journal of Clinical Oncology, Critical Care Medicine and Intensive Care Medicine.

In The Last Decade

Mary Pinder

30 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Pinder Australia 14 386 386 201 150 146 30 995
Monika Raut United States 18 215 0.6× 498 1.3× 302 1.5× 28 0.2× 209 1.4× 70 1.1k
Andja Bojic Austria 16 527 1.4× 280 0.7× 522 2.6× 19 0.1× 163 1.1× 37 1.2k
Shawn Nishi United States 17 127 0.3× 151 0.4× 393 2.0× 51 0.3× 126 0.9× 43 852
Naim Ata Türkiye 18 213 0.6× 217 0.6× 101 0.5× 37 0.2× 211 1.4× 95 1.1k
Danyong Liu China 11 160 0.4× 742 1.9× 292 1.5× 18 0.1× 253 1.7× 26 1.3k
Johnie Rose United States 18 417 1.1× 499 1.3× 180 0.9× 17 0.1× 239 1.6× 77 1.5k
Ian A. Maher United States 14 211 0.5× 178 0.5× 104 0.5× 102 0.7× 269 1.8× 87 1.1k
Robert K. Ausman United States 19 61 0.2× 446 1.2× 292 1.5× 67 0.4× 235 1.6× 60 1.2k
Robin A.P. Weir United Kingdom 16 601 1.6× 51 0.1× 120 0.6× 120 0.8× 363 2.5× 40 1.3k
Ilaria Ardoino Italy 15 140 0.4× 173 0.4× 113 0.6× 15 0.1× 168 1.2× 43 699

Countries citing papers authored by Mary Pinder

Since Specialization
Citations

This map shows the geographic impact of Mary Pinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Pinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Pinder more than expected).

Fields of papers citing papers by Mary Pinder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Pinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Pinder. The network helps show where Mary Pinder may publish in the future.

Co-authorship network of co-authors of Mary Pinder

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Pinder. A scholar is included among the top collaborators of Mary Pinder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Pinder. Mary Pinder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Jeremy, et al.. (2022). Too hot to handle? Assessing the validity and reliability of the College of Intensive Care Medicine "Hot Case” examination. Critical Care and Resuscitation. 24(1). 93–94. 1 indexed citations
2.
Pinder, Mary, et al.. (2021). From dispensary to bedside and beyond: the evolving role of the intensive care unit pharmacist. Journal of Pharmacy Practice and Research. 51(2). 88–89. 1 indexed citations
3.
Venkatesh, Balasubramanian, Charlie Corke, Raymond F. Raper, et al.. (2016). Findings of the bullying, discrimination and sexual harassment survey: response of the College of Intensive Care Medicine. Critical Care and Resuscitation. 18(4). 228–e12. 4 indexed citations
4.
Haren, Frank van, et al.. (2015). Infection control in times of Ebola: how well are we training the next generation of intensivists in Australia and New Zealand?. Critical Care and Resuscitation. 17(2). 65–66. 3 indexed citations
5.
Mehra, Ranee, Aruna Turaka, Joshua E. Meyer, et al.. (2015). Phase I study of vorinostat with concurrent chemoradiotherapy (CRT) for locally advanced non-squamous non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 33(15_suppl). 7553–7553. 1 indexed citations
6.
Ali, Siraj M., Sai‐Hong Ignatius Ou, Jie He, et al.. (2014). Identifying ALK rearrangements that are not detected by FISH with targeted next-generation sequencing of lung carcinoma.. Journal of Clinical Oncology. 32(15_suppl). 8049–8049. 11 indexed citations
7.
Pinder, Mary, Naiyer A. Rizvi, Sarah B. Goldberg, et al.. (2014). A phase 1b open-label study to evaluate the safety and tolerability of MEDI4736, an anti–PD-L1 antibody, in combination with tremelimumab in subjects with advanced non–small cell lung cancer.. Journal of Clinical Oncology. 32(15_suppl). e19137–e19137. 7 indexed citations
8.
Heerden, Peter Vernon van, et al.. (2013). Intensive care unit occupancy after introduction of the emergency department 4-hour discharge rule at a tertiary referral hospital in Western Australia. Critical Care and Resuscitation. 15(4). 318–321. 6 indexed citations
9.
Bepler, Gerold, Charles C. Williams, Michael J. Schell, et al.. (2013). Molecular analysis-directed, international, phase III trial in patients with advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 31(15_suppl). 8001–8001. 3 indexed citations
10.
11.
Gray, Jhanelle E., Alberto Chiappori, Charles C. Williams, et al.. (2013). A phase I/II randomized trial using GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) vaccine in combination with CCL21 in stage IV lung adenocarcinoma: Preliminary results.. Journal of Clinical Oncology. 31(15_suppl). 3091–3091. 1 indexed citations
12.
Gray, Jhanelle E., Eric B. Haura, Alberto Chiappori, et al.. (2010). Phase I study of LBH589 in combination with erlotinib for advanced aerodigestive tract cancers.. Journal of Clinical Oncology. 28(15_suppl). e13016–e13016. 2 indexed citations
13.
Orde, Sam, Antonio Celenza, & Mary Pinder. (2010). A randomised trial comparing a 4-stage to 2-stage teaching technique for laryngeal mask insertion. Resuscitation. 81(12). 1687–1691. 36 indexed citations
14.
Pinder, Mary & Nuhad K. Ibrahim. (2006). Nanoparticle albumin-bound paclitaxel for treatment of metastaticbreast cancer. Drugs of today. 42(9). 599–599. 12 indexed citations
15.
Tan, Hui‐Leng, Mary Pinder, Richard Parsons, Brigit Roberts, & Peter Vernon van Heerden. (2005). Clinical evaluation of USCOM ultrasonic cardiac output monitor in cardiac surgical patients in intensive care unit. British Journal of Anaesthesia. 94(3). 287–291. 113 indexed citations
16.
Gous, Andries, et al.. (2005). Fluid shifts have no influence on ciprofloxacin pharmacokinetics in intensive care patients with intra-abdominal sepsis. International Journal of Antimicrobial Agents. 26(1). 50–55. 32 indexed citations
17.
Lipman, Jeffrey, et al.. (2002). Ciprofloxacin pharmacokinetic profiles in paediatric sepsis: how much ciprofloxacin is enough?. Intensive Care Medicine. 28(4). 493–500. 29 indexed citations
18.
Pinder, Mary, Rinaldo Bellomo, & Jeffrey Lipman. (2002). Pharmacological Principles of Antibiotic Prescription in the Critically Ill. Anaesthesia and Intensive Care. 30(2). 134–144. 87 indexed citations
19.
Pinder, Mary, et al.. (1998). Critical care research and pre-emptive informed consent: a practical approach used in chris hani baragwanath ICU. Intensive Care Medicine. 24(4). 353–357. 10 indexed citations
20.
Power, Bradley, Mary Pinder, L. Peter Hackett, & K F Ilett. (1995). Fatal Serotonin Syndrome following a Combined Overdose of Moclobemide, Clomipramine and Fluoxetine. Anaesthesia and Intensive Care. 23(4). 499–502. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monika Raut Breakdown of academic impact, for papers by Andja Bojic Breakdown of academic impact, for papers by Shawn Nishi Breakdown of academic impact, for papers by Naim Ata Breakdown of academic impact, for papers by Danyong Liu Breakdown of academic impact, for papers by Johnie Rose Breakdown of academic impact, for papers by Ian A. Maher Breakdown of academic impact, for papers by Robert K. Ausman Breakdown of academic impact, for papers by Robin A.P. Weir Breakdown of academic impact, for papers by Ilaria Ardoino
Rankless by CCL
2026